WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped up prior to trading on Wednesday. The stock had previously closed at $11.25, but opened at $12.30. WuXi Biologics (Cayman) shares last traded at $12.6120, with a volume of 7,558 shares traded.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.
Read Our Latest Report on WXXWY
WuXi Biologics (Cayman) Price Performance
The firm’s fifty day simple moving average is $12.81 and its 200-day simple moving average is $10.21.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.
Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.
Read More
- Five stocks we like better than WuXi Biologics (Cayman)
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
- Space Race 2.0: Intuitive Machines Secures Another NASA Contract
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
